Sunder Biomedical Tech. Co., Ltd. (4115.TWO)

TWD 10.35

(-2.36%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 770.19 Million 1.05 Billion 1.13 Billion 910.64 Million -
Cost of Revenue 692.27 Million 913.03 Million 938.83 Million 744.42 Million -
Gross Profit 77.91 Million 140.52 Million 200.78 Million 166.22 Million -
Operating Expenses 77.91 Million 124.99 Million 119.87 Million 103.4 Million -
Selling, General and Administrative Expenses 85.89 Million 95.67 Million 94.24 Million 76.8 Million -
Research and Development Expenses 29.43 Million 29.32 Million 25.62 Million 26.6 Million -
Other Expenses - 5.9 Million 14.88 Million 5.73 Million -
Cost and Expenses 807.6 Million 1.03 Billion 1.05 Billion 847.82 Million -
Operating Income -28.05 Million 22.72 Million 97.01 Million 69.33 Million -
Interest Expense 12.5 Million 10.76 Million 9.18 Million 9.87 Million 11.36 Million
Income Tax Expense -7.36 Million -1.09 Million 16.71 Million 6.52 Million -13.72 Million
Earnings before Tax -40.51 Million 12.22 Million 87.77 Million 59.09 Million -
Net Income -33.15 Million 13.31 Million 71.05 Million 52.57 Million 13.72 Million
Earnings Per Share Basic -0.55 0.22 1.18 0.88 0.23
Earnings Per Share Diluted -0.55 0.22 1.18 0.87 0.23
Weighted Average Shares Outstanding 60 Million 60 Million 60 Million 60 Million 59.64 Million
Weighted Average Shares Outstanding (Diluted) 60 Million 60.05 Million 60.16 Million 60.14 Million 59.64 Million
Gross Margin 0.10 0.13 0.18 0.18 -
EBIT Margin 0.10 0.12 0.17 0.17 -
Profit Margin -0.04 0.01 0.06 0.06 -
EBITDA 76.61 Million 127.48 Million 193.39 Million 154.81 Million 107.17 Million
Earnings Before Tax Margin -0.04 0.02 0.09 0.08 -

Income Statement Charts